<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This work aims at studying the possible alteration of renal renin secretion after human <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> and correlating it to the post <z:hpo ids='HP_0001297'>stroke</z:hpo> neurological and renal function alterations using <z:chebi fb="0" ids="2719,48432">angiotensin II</z:chebi> type 1(AT1) receptor blocker (ARB), <z:chebi fb="0" ids="3347">candesartan</z:chebi>, and beta 1 adrenoreceptor blocker atenolol, which inhibits renin secretion, in Wistar rats subjected to middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Methods  </plain></SENT>
<SENT sid="2" pm="."><plain>This study comprised 21 patients with cerebral <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Seventeen <z:mpath ids='MPATH_458'>normal</z:mpath> persons were used for comparison </plain></SENT>
<SENT sid="4" pm="."><plain>Recumbent and standing plasma renin activity (PRA), reflex plasma renin sensitivity, plasminogen activator inhibitor and <z:chebi fb="0" ids="16737">creatinine</z:chebi> clearance (Ccr) were estimated at admission and two weeks later </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, 60 male Wistar rats were divided into two groups SHAM and ischemic </plain></SENT>
<SENT sid="6" pm="."><plain>Each of the two groups was further subdivided into three subgroups, non-treated, atenolol treated, and <z:chebi fb="0" ids="3347">candesartan</z:chebi> treated </plain></SENT>
<SENT sid="7" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> rats, mean arterial blood pressure (MAP), systolic blood pressure (SBP), diastolic blood pressure (<z:chebi fb="4" ids="35861">DBP</z:chebi>), pulse pressure (PP), heart rate (HR), neurobehavioral evaluation, Ccr, PRA, and <z:mpath ids='MPATH_124'>infarct</z:mpath> size were measured </plain></SENT>
<SENT sid="8" pm="."><plain>Results  </plain></SENT>
<SENT sid="9" pm="."><plain>Together with the significant deterioration of the neurological score, focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in rats resulted in increased PRA and decreased glomerular filtration rate (GFR) </plain></SENT>
<SENT sid="10" pm="."><plain>In <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> patients, GFR was significantly decreased at admission and two weeks later, PRA increased at admission and two weeks later while plasma renin reflex secretion sensitivity had decreased significantly at admission relative to controls, but it increased significantly 2 weeks later </plain></SENT>
<SENT sid="11" pm="."><plain>Atenolol caused significant improvement of the neurobehavioral score and renal function and decrease <z:mpath ids='MPATH_124'>infarct</z:mpath> size of rats subjected to focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> whereas <z:chebi fb="0" ids="3347">candesartan</z:chebi> caused significant improvement of the neurobehavioral score and decreased <z:mpath ids='MPATH_124'>infarct</z:mpath> size with no significant change in GFR </plain></SENT>
<SENT sid="12" pm="."><plain>Neither atenolol nor <z:chebi fb="0" ids="3347">candesartan</z:chebi> caused significant change in MAP, SBP, <z:chebi fb="4" ids="35861">DBP</z:chebi>, PP and HR Conclusion  </plain></SENT>
<SENT sid="13" pm="."><plain>(1) <z:hpo ids='HP_0002140'>Ischemic stroke</z:hpo> seems to be associated with a postischemic increase of the plasma renin secretion, which may increase the <z:mpath ids='MPATH_124'>infarct</z:mpath> size in the brain and may induce <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0000083'>renal insufficiency</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>(2) This study confirms that Atenolol and ARBs could benefit <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> patients without altering blood pressure </plain></SENT>
</text></document>